Articles tagged "Heart failure"

2021 American Transplant Congress
Mortality from Fulminant Myocarditis in Multi-organ Transplant Recipient with Covid-19
K. Mahendraraj, I. Kim, T. Todo, T. Brennan, N. Nissen, K. Kosari, G. Voidonikolas, D. Ramzy
Transplant Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Novel coronavirus infection has been rarely described in multi-organ transplantation. This case highlights the poor prognosis associated with cardiac involvement by SARS-Cov-2 in transplantation,…
2021 American Transplant Congress
The Seattle Heart Failure Model is a Predictor of Mortality After Kidney Transplant in Patients with End Stage Renal Disease and Heart Impairment
A. Perez-Gutierrez¹, P. J. Bachul², D. N. Danz³, B. Juengel², M. Josephson², J. Fung², P. Witkowski², B. Chung⁴, Y. Becker²
¹Surgery, University of Chicago, Chicago, IL, IL, ²Surgery, University of Chicago, Chicago, IL, ³Economics, University of Pittsburgh, Pittsburgh, IL, ⁴Cardiology, University of Chicago, Chicago, IL
*Purpose: Cardiovascular disease is the main cause of mortality after kidney transplantation. Many patients with ESRD have heart failure that is attributed to fluid overload.…
2021 American Transplant Congress
An Unexpected Case of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Overlooked Pretransplant, but Then Diagnosed Early After Kidney Transplant with a Negative Patient Outcome: A Case Report
W. Hoffman, M. Waybill, H. Yang, D. Ladie, M. Singh
UPMC Pinnacle Transplant, Harrisburg, PA
*Purpose: ATTR-CM is underrecognized and commonly overlooked and undiagnosed. When found it is often a late diagnosis in patients with severe left ventricular hypertrophy (LVH)…
2021 American Transplant Congress
Simultaneous Heart-Liver-Kidney Transplantation Survival: National and Single-Center Outcomes
U. A. Siddiqi¹, P. S. Combs¹, G. Kim², T. Baker³, Y. Becker¹, V. Jeevanandam¹
¹Section of Cardiac Surgery, University of Chicago Medicine, Chicago, IL, ²Section of Cardiology, University of Chicago Medicine, Chicago, IL, ³University of Chicago Medicine, Chicago, IL
*Purpose: Simultaneous Heart-Liver-Kidney transplantation (SHLKTx) is an incredibly rare, high-risk operation undergone by well-selected patients presenting with multi-organ failure. Our center has performed 10 of…
2021 American Transplant Congress
Geographic Variation in Candidate Listing Behavior Under the New Heart Allocation Policy
G. Ran¹, K. Chung¹, A. S. Anderson², R. Gibbons³, N. Narang⁴, M. Churpek⁵, W. F. Parker¹
¹Pritzker School of Medicine, University of Chicago, Chicago, IL, ²Department of Medicine, University of Texas San Antonio, San Antoion, TX, ³Department of Medicine, University of Chicago, Chicago, IL, ⁴Department of Medicine, University of Illinois-Chicago, Chicago, IL, ⁵Department of Medicine, University of Wisconsin, Madison, WI
*Purpose: Describe and explain variations in listing practice among U.S. transplant centers in response to the new allocation policy.*Methods: We performed an observational cohort study…
2020 American Transplant Congress
UNOS Registry Myocarditis Heart Transplantation Outcome
J. P. Li¹, P. Kingsford¹, S. Nuno¹, D. Miklin¹, G. Liu², J. Rahman², K. Pandya², C. Lum³, P. Banankhah², P. Genyk¹, D. Vucicevic⁴, A. Wolfson⁵, R. Chand⁶, K. Yang¹, S. Shah¹, A. Kiankhooy⁷, J. Nattiv², S. Hashmi¹, J. Pizula¹, A. Lee¹, M. Fong², L. Grazette², E. C. DePasquale², A. S. Vaidya²
¹Internal Medicine, Keck Medicine of USC, Los Angeles, CA, ²Cardiology, Keck Medicine of USC, Los Angeles, CA, ³Internal Medicine, The Queen's Medical Center, Honolulu, HI, ⁴Cardiology, Newark Beth-Israel Medical Center, Newark, NJ, ⁵Cardiology, University of Arizona Sarver Heart Center, Tuscon, AZ, ⁶Cardiology, Harbor-UCLA Medical Center, Los Angeles, CA, ⁷Cardiothoracic Surgery, Keck Medicine of USC, Los Angeles, CA
*Purpose: Hospitalized myocarditis patients have a variable course that can require heart transplantation at a rate of about 3-4%. We sought to evaluate the post-transplant…
2020 American Transplant Congress
Post Heart Transplant Outcomes for Patients with Cardiac Sarcoidosis
G. S. Liu¹, E. C. DePasquale¹, A. M. Wolfson², R. R. Chand³, P. Banankhah¹, J. Nattiv¹, A. D. Salimbangon⁴, P. A. Genyk¹, P. A. Kingsford¹, J. P. Li¹, D. Vucicevic⁵, K. Pandya¹, J. Rahman¹, M. Fong¹, A. S. Vaidya¹
¹Keck Medicine of USC, Los Angeles, CA, ²University of Arizona Sarver Heart Center, Tucson, AZ, ³Harbor-UCLA Medical Center, Los Angeles, CA, ⁴UCLA Medical Center, Los Angeles, CA, ⁵Newark Beth Israel Medical Center, Newark, NJ
*Purpose: Cardiac sarcoidosis (CS) is a known etiology of end-stage dilated, hypertrophic, or arrhythmogenic cardiomyopathies requiring heart transplantation (HT). We sought to evaluate the long-term…
2020 American Transplant Congress
Takotsubo Cardiomyopathy Following Liver Transplantation: A Single Center Experience
O. Shamaa¹, S. Jafri¹, M. Shamaa², K. Brown¹, D. Venkat¹
¹Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI, ²General Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Takotsubo cardiomyopathy also known as apical ballooning syndrome and stress-induced cardiomyopathy is a syndrome characterized by regional left ventricular systolic dysfunction that resembles myocardial…
2020 American Transplant Congress
Challenges in Examining Transplant Outcomes in Patients with Fontan-Associated Liver Disease
R. T. Fischer¹, M. H. Kim², A. Nguyen³, S. R. Kumar³, J. Bucuvalas⁴, E. F. Glynn¹, M. A. Hoffman¹, J. Emamaullee³
¹Children's Mercy Hospital, Kansas City, MO, ²Children's Hospital-Los Angeles, Los Angeles, CA, ³University of Southern California, Los Angeles, CA, ⁴Mount Sinai Kravis Children's Hospital, New York, NY
*Purpose: The Fontan procedure has allowed patients born with single ventricle physiology to survive into adulthood. It is projected that the mean age of Fontan…
2020 American Transplant Congress
Prevalence, Prognosis and Predictors of Neurological Complications after Heart Transplantation
C. Caraviello, D. Harsanyi, L. Trevizan, F. Bacal, S. Mangini
Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil
*Purpose: Heart transplantation (HT) is considered the gold-standard treatment for end-stage heart failure. In spite of its innumerous benefits, this therapy still involves complications. Among…

1
2
3
…
5
Next Page »